🇺🇸 FDA
Pipeline program

Intermittent hepatic inflow occlusion (IHIO)

2007-09-096

Phase 3 other active

Quick answer

Intermittent hepatic inflow occlusion (IHIO) for End Stage Liver Disease is a Phase 3 program (other) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Samsung Bioepis NL B.V.
Indication
End Stage Liver Disease
Phase
Phase 3
Modality
other
Status
active

Clinical trials